Safety and Efficacy Study of Bimatoprost in the Treatment of Men With Androgenic Alopecia

NCT01325337 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

307

Enrollment

INDUSTRY

Sponsor class

Conditions

Alopecia
Alopecia, Androgenetic
Baldness

Interventions

DRUG: bimatoprost Formulation A
DRUG: bimatoprost Formulation B
DRUG: bimatoprost Formulation C
DRUG: bimatoprost vehicle solution
DRUG: minoxidil 5% solution

Sponsor

Allergan